ARDEX AF 495 Component B

Hazard statements (CLP)

H315, H317, H319, H332, H334, H335, H351, H373

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice

Hazard pictograms

GHS07 GHS08

Signal word

Danger

Contains

polymethylene polyphenyl isocyanate

Hazard statements

H332 - Harmful if inhaled. H315 - Causes skin irritation. H319 - Causes serious eye irritation. H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled. H317 - May cause an allergic skin reaction. H335 - May cause respiratory irritation. H351 - Suspected of causing cancer. H373 - May cause damage to organs through prolonged or repeated exposure.

Precautionary statements

P102 - Keep out of reach of children. P202 - Do not handle until all safety precautions have been read and understood. P260 - Do not breathe mist, vapours, spray, gas. P280 - Wear eye protection, protective gloves. P304+P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P332+P313 - If skin irritation occurs: Get medical advice/attention. P337+P313 - If eye irritation persists: Get medical advice/attention.

Supplemental label elements

EUH204 - Contains isocyanates. May produce an allergic reaction.

Additional information

Dispose of contents/container in accordance with regional/national/international/local regulations. As from 24 August 2023 adequate training is required before industrial or professional use.

PBT Substances

not relevant – no registration required

vPvB Substances

not relevant – no registration required Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component polymethylene polyphenyl isocyanate(9016-87-9) The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Acute toxicity (inhalation:vapour) Category 4 H332 Skin corrosion/irritation, Category 2 H315 Serious eye damage/eye irritation, Category 2 H319 Respiratory sensitisation, Category 1 H334 Skin sensitisation, Category 1 H317 Carcinogenicity, Category 2 H351 Specific target organ toxicity – Single exposure, Category 3, Respiratory H335 tract irritation Specific target organ toxicity – Repeated exposure, Category 2 H373 Full text of H- and EUH-statements: see section 16 3/17/2023 (Revision date) Adverse physicochemical, human health and environmental effects To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice.